Hugh Nicholson, PhD

Hugh Nicholson, PhD, has a diverse work experience in the field of scientific research and project management. Hugh currently holds the position of Scientific Project Manager at SOLASTA Bio since April 2023. Prior to this, they worked as a Molecular Scientist at Merck Life Science from November 2021 to April 2023.

Hugh's academic background includes a research PhD at the University of Dundee, where they focused on understanding the mechanisms of fibroblast growth factor 1-induced chemotherapy resistance in ovarian cancer. Hugh investigated the role of FGF1 in drug resistance and examined the influence of inter-patient differences on FGF1 signaling in disease progression and chemotherapy response. This role lasted from October 2016 to June 2021.

Hugh also gained experience as a Laboratory Research Assistant at the University of California, Berkeley in 2015, working under Professor Robert Fischer on demethylation enzymes in Arabidopsis thaliana. During this time, they participated in various experiments, including mutational PCR, agarose gel electrophoresis, and restriction digestion.

Additionally, Hugh worked as a Laboratory Research Assistant at the Moredun Research Institute in 2014, where they shadowed the immunoparasitology research group. Hugh learned about ELISA techniques, affinity column elution chromatography, SDS-PAGE, and the growth and distinction of raw materials for experimental work. The group's vaccine for the ruminant roundworm Haemonchus contortus, known as Barbervax®, is now commercially available.

Overall, Hugh Nicholson, PhD, possesses expertise in molecular biology, cancer research, and project management, with a strong academic and practical background in scientific research.

Hugh Nicholson, PhD, has an education history that includes a Bachelor of Science (BSc Hons) in Biology/Biological Sciences from the University of Dundee. Hugh obtained this degree between 2012 and 2016. Building on their undergraduate education, Hugh pursued a Doctorate of Philosophy (PhD) in Oncology and Cancer Biology at the same university. Hugh completed their PhD program from 2016 to 2021. Additionally, Hugh possesses a Disclosure Scotland PVG Certification, obtained from The Scottish Government, although the specific month and year of obtaining this certification are not provided.